| Oxidative stress and inflammation in Parkinson's disease: is there a causal link? A Hald, J Lotharius Experimental neurology 193 (2), 279-290, 2005 | 634 | 2005 |
| Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain A Hald, S Nedergaard, RR Hansen, M Ding, AM Heegaard European journal of pain 13 (2), 138-145, 2009 | 179 | 2009 |
| Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin M Matsumoto, M Inoue, A Hald, W Xie, H Ueda Journal of Pharmacology and Experimental Therapeutics 318 (2), 735-740, 2006 | 152 | 2006 |
| Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis BC Martel, T Litman, A Hald, H Norsgaard, P Lovato, B Dyring‐Andersen, ... Experimental dermatology 25 (6), 453-459, 2016 | 77 | 2016 |
| Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis DH Madsen, HJ Jürgensen, S Ingvarsen, MC Melander, B Vainer, ... The Journal of pathology 227 (1), 94-105, 2012 | 56 | 2012 |
| Spinal astrogliosis in pain models: cause and effects A Hald Cellular and molecular neurobiology 29, 609-619, 2009 | 46 | 2009 |
| Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain A Hald, M Ding, K Egerod, RR Hansen, D Konradsen, SG Jørgensen, ... Pharmacology Biochemistry and Behavior 91 (1), 38-46, 2008 | 44 | 2008 |
| Inflammation in Parkinson’s disease: causative or epiphenomenal? A Hald, J Van Beek, J Lotharius Inflammation in the Pathogenesis of Chronic Diseases: The COX-2 Controversy …, 2007 | 42 | 2007 |
| Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test M Matsumoto, M Inoue, A Hald, A Yamaguchi, H Ueda Molecular Pain 2, 1744-8069-2-16, 2006 | 41 | 2006 |
| Skin wound healing in MMP2‐deficient and MMP2/plasminogen double‐deficient mice S Frøssing, B Rønø, A Hald, J Rømer, LR Lund Experimental Dermatology 19 (8), e234-e240, 2010 | 40 | 2010 |
| Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180 LH Engelholm, MC Melander, A Hald, M Persson, DH Madsen, ... The Journal of pathology 238 (1), 120-133, 2016 | 33 | 2016 |
| Gender affects skin wound healing in plasminogen deficient mice B Rønø, LH Engelholm, LR Lund, A Hald PloS one 8 (3), e59942, 2013 | 29 | 2013 |
| Differential actions of the endocytic collagen receptor uPARAP/Endo180 and the collagenase MMP-2 in bone homeostasis DH Madsen, HJ Jürgensen, S Ingvarsen, MC Melander, R Albrechtsen, ... PLoS One 8 (8), e71261, 2013 | 28 | 2013 |
| LPS counter regulates RNA expression of extracellular proteases and their inhibitors in murine macrophages A Hald, B Rønø, LR Lund, KL Egerod Mediators of Inflammation 2012, 2012 | 23 | 2012 |
| Expression of C4. 4A, a structural uPAR homolog, reflects squamous epithelial differentiation in the adult mouse and during embryogenesis MC Kriegbaum, B Jacobsen, A Hald, M Ploug Journal of Histochemistry & Cytochemistry 59 (2), 188-201, 2011 | 23 | 2011 |
| Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate S Emmert, HA Haenssle, JR Zibert, M Schön, A Hald, MH Hansen, ... PLoS One 11 (9), e0160096, 2016 | 21 | 2016 |
| Cancer‐induced bone loss and associated pain‐related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE‐10790 A Hald, RR Hansen, MW Thomsen, M Ding, PI Croucher, O Gallagher, ... International journal of cancer 125 (5), 1177-1185, 2009 | 21 | 2009 |
| Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling IK Lund, BS Nielsen, K Almholt, B Rønø, A Hald, M Illemann, KA Green, ... Developmental biology 358 (1), 56-67, 2011 | 18 | 2011 |
| MMP9 is protective against lethal inflammatory mass lesions in the mouse colon A Hald, B Rønø, MC Melander, M Ding, S Holck, LR Lund Disease models & mechanisms 4 (2), 212-227, 2011 | 17 | 2011 |
| Repeated treatments with ingenol mebutate prevents progression of UV-induced photodamage in hairless mice AM Erlendsson, D Thaysen-Petersen, C Bay, A Hald, K Skak, JR Zibert, ... PLoS One 11 (9), e0162597, 2016 | 7 | 2016 |
